Solara Active PP

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IN9624Z01022
  • NSEID: SOLARAPP1
  • BSEID: 890202
INR
308.70
0.00 (0.00%)
BSENSE

May 06

BSE+NSE Vol: 3.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039292,
    "name": "Solara Active PP",
    "stock_name": "Solara Active PP",
    "full_name": "Solara Active Pharma Sciences Ltd Partly Paidup",
    "name_url": "stocks-analysis/solara-active-pp",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "308.70",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "308.70",
    "mcapval": "370.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 890202,
    "symbol": "SOLARAPP1",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "IN9624Z01022",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "3.45 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/solara-active-pp-10039292-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 169,
    "sid": "10039292",
    "stock_news_url": "https://www.marketsmojo.com/news/solara-active-pharma-sciences-ltd-partly-paidup-10039292"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "28-Apr-2026",
      "details": "Solara Active Pharma Sciences has informed the exchange about the Press Release titled Solara is pleased to announce the successful completion of US FDA inspection of its Puducherry Facility with continued state of cGMP Compliance.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Apr-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the Exchange about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice",
      "source": "BSE"
    }
  ],
  "corporate_actions": []
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Apr-2026 | Source : BSE

Solara Active Pharma Sciences has informed the exchange about the Press Release titled Solara is pleased to announce the successful completion of US FDA inspection of its Puducherry Facility with continued state of cGMP Compliance.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Apr-2026 | Source : BSE

Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

08-Apr-2026 | Source : BSE

Solara Active Pharma Sciences Limited has informed the Exchange about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice

stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available